Valion Bio VBIO
NASDAQ VBIO
$0.54 +0.02 (+3.85%)
At close: Nov 13, 2026 · 4:00 PM EST

Valion Bio (VBIO) Notes Payables (2020 - 2024)

Updated

Analysis

Valion Bio (VBIO) Notes Payables (2020 - 2024) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,359.75 Bn 1,333.37 Bn 20.46 Bn
2 Johnson & Johnson 688.76 Bn 608.62 Bn 17.30 Bn
3 AbbVie 521.69 Bn 489.75 Bn 13.12 Bn
4 Merck 364.31 Bn 327.31 Bn 13.19 Bn
5 Novartis Ag 306.35 Bn 279.93 Bn -
6 Astrazeneca 285.96 Bn 259.56 Bn 13.26 Bn
7 Amgen 251.88 Bn 203.53 Bn 7.58 Bn
8 Gilead Sciences 208.59 Bn 183.61 Bn 6.73 Bn
9 Pfizer 164.73 Bn 112.38 Bn 12.56 Bn
10 Valion Bio 73,008.00 -25.39 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2024 180,000.00
Dec 31, 2023 193,000.00
Sep 30, 2023 173,000.00
Jun 30, 2023 185,000.00
Mar 31, 2023 182,000.00
Dec 31, 2022 163,000.00
Sep 30, 2022 160,000.00
Jun 30, 2022 170,000.00
Mar 31, 2022 168,000.00
Dec 31, 2021 163,000.00
Dec 31, 2020 36,000.00
API Access

Valion Bio Notes Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=notes-payables&ticker=VBIO&period=max&api_key=YOUR_API_KEY